London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Kettle - I agree! I believe there is a few options for funding if the FDA's decision goes our way!
In saying that the FDA's decision is based on data and as much as they may have queries and need for additional data, Iclaprim has performed well in each of the trials.
I by all means am no expert and barely understand it, but I recon and hope it will come down to labeling!
Iclaprim as an antibiotic is a needed tool for modern medicine, so again I hope this is something well considered.
But it is binary, FDA either kill it and this would kill any chance of financing or FDA keep it alive and am sure that options will arise.
I also believe that MTFB will know or have a good idea as to what the FDA want and are probably lining things up! Or atleast I would expect them to.
Not literally bleeding stock, I meant bleedin stock as a pain in the bottom. Not a Scott type decamp.
Yes I get you Max but I do not see money being available as a share builder, the Fda decision or request is the only way foreward or down. Nothing else will make a significant gain. I see a 25 p jump but before then pennies up and down. Boy I hope i am wrong and it starts rising now but being a Lth this is just the norm for this bleeding stock.
Kettle- if you are correct and it's because shorters are getting gitters, that would be a huge positive sign. As we all know there are no whispers or insiders and no body knows until the RNs (as I told my Nana).
The point is, if it's shorters closing positions, because MTFB went as low as it is going to go (unless no funding because the meeting is a disaster), then both shorters and savvy investors will come in.
As far as the meeting goes, you would think that there are enough serious professionals inked to MTFB, that the company would probably have a really good idea as to what to expect and mbe this is why Hercules is being patient! Just some thoughts and we'll see
It is fun though I can remember a realistic price of 80 pence before that fateful Fda decision.
I think it’s the start of most thinking - fickit- I’m holding now. Had 6 months of churn and the dust is settling with holders now prepared to wait and see. It’s a unique opp but with unique risks
Surely the meeting next month comes first before a boooooommmmmmm ! I cannot see this as the start to anything. Apart from shooters getting a real worry Scott.
Jimzi- what do you think they are working? Any sign on L2?
By when?
Chances low but too many unknown variables to assess
1] What further work is required
2] How much will it cost
3] Terms of a raise
4] Are they in partnership talks
5] Sell parts of the world rights?
Thats why we are 2.5p -
Good answers to everything then yes - but we live in a nasty business world so doubt they will get the whole wish list - but who knows
But they keep having to reload the ask to keep a lid on it - good sign -they are working hard to stop a rise - ask WHY?
Cdog7- let's get to the 5p point, then 7.5p... before worrying about £1
For it to hit £1 Iclaprim has to be proved and before that we need to get the study in order to get the info, before the study we need to know what we need to find out, before that we need money and once all this is sorted. Then we can start talking £1+
Serious question.
As speculative as it may be but I like calculations.
Can anyone not holding short positions, tell me the chances of this hitting £1, if so, what would need to happen for it to achieve that?
And I mean £1 from current uk value. not £1 from nasdaq price.
As said before, speculative but im looking to be speculative for the moment.